Targeting Mitochondrial Dysfunction for the Treatment of Diabetic Complications: Pharmacological Interventions through Natural Products
- PMID: 28989247
- PMCID: PMC5628518
- DOI: 10.4103/phrev.phrev_41_16
Targeting Mitochondrial Dysfunction for the Treatment of Diabetic Complications: Pharmacological Interventions through Natural Products
Abstract
Diabetes mellitus is a chronic hyperglycemic condition with deleterious effects on microcirculation, resulting in diabetic complications. Chronic hyperglycemia induces the generation of reactive oxygen species (ROS), which are the key pathological triggers in the development of diabetic complications. ROS are responsible for the activation of various pathways involved in the genesis of diabetic complications, mitochondrial dysfunction, as well as insulin resistance. The review describes normal mitochondrial physiology and abnormal alterations, which occur in response to hyperglycemia. Mitochondrial biogenesis is a highly regulated process mediated by several transcription factors, wherein mitochondrial fusion and fission occur in harmony in a normal healthy cell. However, this harmony is disrupted in hyperglycemic condition indicated by alteration in functions of essential transcription factors. Hyperglycemia-induced mitochondrial dysfunction plays a key role in diabetic complications, pancreatic β-cell dysfunction, as well as skeletal muscle insulin resistance as demonstrated by various in vitro, preclinical, and clinical studies. The review focuses on the various factors involved in mitochondrial biogenesis and maintenance of healthy mitochondrial function. Several phytoconstituents act through these pathways, either directly by stimulating biogenesis or indirectly by inhibiting or preventing dysfunction, and produce a beneficial effect on overall mitochondrial function. These phytoconstituents have enormous potential in amelioration of diabetic complications by restoring normal mitochondrial physiology and need detailed evaluation by preclinical and clinical studies. Such phytoconstituents can be included as nutraceuticals or adjuvant therapy to the mainstream treatment of diabetes.
Keywords: Diabetic complications; mitochondrial dysfunction; natural products; phytoconstituents; reactive oxygen species.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Mitochondrial biogenesis: pharmacological approaches.Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118. Curr Pharm Des. 2014. PMID: 24606795
-
Puerarin attenuates palmitate-induced mitochondrial dysfunction, impaired mitophagy and inflammation in L6 myotubes.Life Sci. 2018 Aug 1;206:84-92. doi: 10.1016/j.lfs.2018.05.041. Epub 2018 May 23. Life Sci. 2018. PMID: 29802940
-
The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus.Arch Pharm Res. 2024 Mar 14. doi: 10.1007/s12272-024-01490-5. Online ahead of print. Arch Pharm Res. 2024. PMID: 38485900 Review.
-
Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients.J Clin Endocrinol Metab. 2012 Jan;97(1):E59-64. doi: 10.1210/jc.2011-1760. Epub 2011 Oct 19. J Clin Endocrinol Metab. 2012. PMID: 22013100 Clinical Trial.
-
Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.Curr Pharm Des. 2013;19(32):5695-703. doi: 10.2174/1381612811319320005. Curr Pharm Des. 2013. PMID: 23448484 Review.
Cited by
-
'Oxidative stress'-A new target in the management of diabetes mellitus.J Family Med Prim Care. 2023 Nov;12(11):2552-2557. doi: 10.4103/jfmpc.jfmpc_2249_21. Epub 2023 Nov 21. J Family Med Prim Care. 2023. PMID: 38186790 Free PMC article. Review.
-
Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease.Antioxidants (Basel). 2023 Mar 7;12(3):658. doi: 10.3390/antiox12030658. Antioxidants (Basel). 2023. PMID: 36978905 Free PMC article. Review.
-
Type 2 diabetes mellitus induced autophagic response within pulmonary tissue in the rat model.Bioimpacts. 2023;13(1):43-50. doi: 10.34172/bi.2022.22183. Epub 2022 Jun 8. Bioimpacts. 2023. PMID: 36817001 Free PMC article.
-
Impairment of Mitochondrial Respiration in Metabolic Diseases: An Overview.Int J Mol Sci. 2022 Aug 9;23(16):8852. doi: 10.3390/ijms23168852. Int J Mol Sci. 2022. PMID: 36012137 Free PMC article. Review.
-
Chronic Hyperglycemia Compromises Mitochondrial Function in Corneal Epithelial Cells: Implications for the Diabetic Cornea.Cells. 2022 Aug 18;11(16):2567. doi: 10.3390/cells11162567. Cells. 2022. PMID: 36010643 Free PMC article.
References
-
- Michael JF. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26:77–82.
-
- Immo ES. In: Mitochondrial electron transport and oxidative phosphorylation. Mitochondria, editor. New York: John Wiley & Sons; 1999. pp. 141–245.
-
- Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54:1615–25. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources